» Articles » PMID: 29867905

Probiotic ProBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2018 Jun 6
PMID 29867905
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

This study was designed to evaluate the protective effect of ethanol extract (SEL001) isolated from a potent probiotic strain proBio-65 on imiquimod (IMQ)-induced psoriasis-like skin inflammation in a mouse model. Histopathological and histomorphometrical changes in the ear and dorsal skin tissues were observed under hematoxylin and eosin stain for general histopathological architectures or Masson's trichrome stain for collagen fibers. The expression profile of psoriasis-associated specific genes was determined using Real-Time PCR analysis. As a result, topical application of IMQ resulted in a significant increase of mean total and epithelial (epidermis) thicknesses, the number of inflammatory cells infiltrated in the dermis, and the decrease of dermis collagen fiber occupied regions in the ear tissues of IMQ and IMQ plus vaseline treated groups when compared to the intact control group. A significant increase of epithelial thickness and number of inflammatory cells infiltrated in the dermis of dorsal skin tissues were also noticed in IMQ and IMQ plus vaseline treated groups as compared to the intact control group, suggesting classic IMQ-induced hypersensitive psoriasis. IMQ-induced hypersensitive psoriasis related histopathological changes to the ear and dorsal skin tissues were significantly inhibited by the treatment of a standard drug clobetasol and SEL001. Further, mRNA expression analysis indicated a significant increase in gene expression levels of pro-inflammatory cytokines, including IL-19, IL-17A, and IL-23 in IMQ and IMQ plus vaseline treated groups than that of the control. Clobetasol and SEL001 treated groups resulted in a lower gene expression level of IL-19, IL-17A, and IL-23 as compared to IMQ and IMQ plus vaseline treated groups. These results enforce that SEL001 could be a novel treatment for psoriasis and an alternative to other drugs that pose a number of side effects on the skin.

Citing Articles

New horizons in the treatment of psoriasis: Modulation of gut microbiome.

Memariani M, Memariani H Heliyon. 2025; 11(1):e41672.

PMID: 39866422 PMC: 11760288. DOI: 10.1016/j.heliyon.2025.e41672.


Limonin alleviates imiquimod-induced psoriasis-like skin inflammation in mice model by downregulating inflammatory responses.

Li Q, Li F, Wang T Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39702598 DOI: 10.1007/s00210-024-03655-x.


The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies.

Radaschin D, Tatu A, Iancu A, Beiu C, Popa L Medicina (Kaunas). 2024; 60(10).

PMID: 39459406 PMC: 11509136. DOI: 10.3390/medicina60101619.


Global Trends and Scientific Impact of Topical Probiotics in Dermatological Treatment and Skincare.

Alves A, Martins Jr S, Belo J, Lemos M, de Matos Chaves Lima C, Silva C Microorganisms. 2024; 12(10).

PMID: 39458319 PMC: 11510400. DOI: 10.3390/microorganisms12102010.


Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model.

Guillaume P, Rupp T, Froget G, Goineau S Int J Mol Sci. 2024; 25(17).

PMID: 39273201 PMC: 11395139. DOI: 10.3390/ijms25179254.


References
1.
Kim J, Park B, Park H, Park Y, Kim B, Pyo S . Atopic dermatitis-mitigating effects of new Lactobacillus strain, Lactobacillus sakei probio 65 isolated from Kimchi. J Appl Microbiol. 2013; 115(2):517-26. DOI: 10.1111/jam.12229. View

2.
Ravi B, Renitta R, Prabha M, Issac R, Naidu S . Evaluation of antidiabetic potential of oyster mushroom (Pleurotus ostreatus) in alloxan-induced diabetic mice. Immunopharmacol Immunotoxicol. 2012; 35(1):101-9. DOI: 10.3109/08923973.2012.710635. View

3.
Park C, Youn M, Jung Y, Kim H, Jeong Y, Lee H . New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse. J Med Food. 2008; 11(3):405-12. DOI: 10.1089/jmf.2007.0144. View

4.
Kim H, Rather I, Kim H, Kim S, Kim T, Jang J . A Double-Blind, Placebo Controlled-Trial of a Probiotic Strain Lactobacillus sakei Probio-65 for the Prevention of Canine Atopic Dermatitis. J Microbiol Biotechnol. 2015; 25(11):1966-9. DOI: 10.4014/jmb.1506.06065. View

5.
Perera G, Di Meglio P, Nestle F . Psoriasis. Annu Rev Pathol. 2011; 7:385-422. DOI: 10.1146/annurev-pathol-011811-132448. View